US Corporate Distress Financial Stress SEC Filings — April 23, 2026

23-04-2026

GCI Holdings, LLC, a wholly owned subsidiary of GCI Liberty, Inc. (Nasdaq: GLIBA, GLIBK), announced a definitive agreement to acquire 100% of Quintillion (Q Gateway Intermediate Holdings, LLC) for a $310 million enterprise value, subject to adjustments, including reimbursement of up to $50 million in qualifying capital expenditures for the Nome-to-Homer Express project and a $160 million unsecured loan provided shortly after signing. The deal combines Quintillion’s 1,800+ miles of existing fiber and ~1,500 miles of planned expansion with GCI’s statewide network to enhance reliability, resiliency, and performance in Alaska’s challenging environments. No financial performance declines or flat metrics are reported; the acquisition supports strategic goals like national defense and broadband expansion without noted disruptions to existing services.

• ·Closing anticipated following regulatory approval and customary conditions.
• ·Additional consideration payable in 2028, 2029, and 2031 via post-closing earnout based on financial metrics.
• ·Quintillion operates primarily on wholesale basis, supporting carriers, healthcare, education, and public safety.
• ·Press release dated April 22, 2026; SEC 8-K filed April 23, 2026.

23-04-2026

Nektar Therapeutics announced the pricing of an upsized $325 million public offering of 3,532,609 shares of common stock at $92.00 per share, with gross proceeds expected to be approximately $325 million before expenses. The company granted underwriters a 30-day option to purchase up to an additional 529,891 shares. Net proceeds will fund general corporate purposes, including research and development, clinical development such as Phase 3 trials for rezpegaldesleukin in atopic dermatitis and alopecia areata, and manufacturing.

• ·Offering expected to close on April 23, 2026, subject to customary conditions.
• ·Underwriters: Jefferies, TD Cowen, and Piper Sandler as joint bookrunning managers; Citigroup as bookrunner.
• ·Pursuant to shelf registration statement on Form S-3ASR (No. 333-291466) filed November 12, 2025.

23-04-2026

Brand Engagement Network Inc. entered into a Securities Purchase Agreement with Ben Capital Fund I, LLC on April 21, 2026, for a private placement of 25,492 shares of common stock at $39.25 per share (120% of the April 21 closing price), yielding gross proceeds of $1,000,561 with 100% warrant coverage; the first installment of $250,101 closed immediately, and the remaining $750,460 is expected before May 29, 2026. Additionally, the Company received $1,114,164 in cash from warrant exercises during April. No declines or flat metrics were reported.

• ·Securities offered and sold pursuant to exemptions from registration requirements of the Securities Act of 1933.
• ·Company qualifies as an emerging growth company.

23-04-2026

On April 17, 2026, Idaho Copper Corporation closed a private offering of $1,357,947 in principal amount of convertible promissory notes due in 12 months at an initial conversion price of $6.00 per share, along with warrants to purchase 226,332 shares at $7.50 per share exercisable for 5 years. Of the total, $102,947 in existing notes were converted on a dollar-for-dollar basis by two investors. ThinkEquity LLC served as exclusive placement agent, receiving fees and warrants for 10% of the shares issuable upon note conversion.

• ·Issuance exempt under Section 4(a)(2) and Rule 506(b) of Regulation D to accredited investors only.
• ·Notes bear no interest unless default, then 18% per annum.
• ·Automatic conversion upon national exchange listing at lower of 70% of offering price or $6.00.
• ·Forms filed as Exhibits: 4.1 (Warrant), 10.1 (Subscription Agreement), 10.2 (Note).

23-04-2026

On April 19, 2026, SBC Medical Group Holdings Incorporated entered into an underwriting agreement with Maxim Group LLC for the sale of 3,100,000 shares of its common stock by Dr. Yoshiyuki Aikawa, the CEO and Chairman as selling stockholder; the underwriters received a 45-day option for up to 465,000 additional shares. The offering closed on April 21, 2026, with no shares sold by the Company and no proceeds received by it. This secondary offering was conducted pursuant to a Form S-3 registration statement filed on December 29, 2025.

• ·Underwriting Agreement filed as Exhibit 1.1
• ·Pursuant to Registration Statement on Form S-3 (File No. 333-292451), filed December 29, 2025
• ·Company is an emerging growth company

23-04-2026

Goldman Sachs Private Credit Corp., acting as equityholder and investment advisor, along with borrower GS Private Credit SPV Public I LLC, entered into the Fourth Amendment to the Revolving Credit and Security Agreement on April 17, 2026, with BNP Paribas as administrative agent and lender, and State Street Bank and Trust Company as collateral agent. The amendment modifies the facility originally dated September 28, 2023, following prior amendments on May 30, 2024, October 31, 2024, and January 31, 2025, with changes detailed in Appendix A (not provided). The parties represent no Default or Event of Default exists, and all prior representations and warranties remain true and correct.

• ·Amendment effective upon execution, payment of fees, consents/approvals, and receipt of legal opinion from Dechert LLP.
• ·Governed by New York law.

23-04-2026

Coeur Mining, Inc. announced the final results of its exchange offer and consent solicitation for New Gold Inc.'s US$400,000,000 6.875% Senior Notes due 2032, with US$385,800,000 aggregate principal amount (96.45% of outstanding) validly tendered and accepted in exchange for US$385,774,000 in new Coeur 6.875% Senior Notes due 2032 and approximately US$771,600 in cash. The exchange supports integration of New Gold into Coeur's operations, including mines like New Afton, Rainy River, and others. No significant declines noted, with high tender participation indicating strong holder support.

• ·Early Participation Date: April 3, 2026 (5:00 p.m. New York City time)
• ·Expiration Date: April 20, 2026 (5:00 p.m. New York City time)
• ·Settlement Date: April 22, 2026
• ·Exchange Offer Memorandum dated March 23, 2026
• ·Remaining untendered Existing Notes: US$14,200,000 (3.55%)

23-04-2026

On April 17, 2026, Clean Energy Technologies, Inc. received a Nasdaq notice for non-compliance with Listing Rule 5250(c)(1) due to failure to file its Form 10-K for the fiscal year ended December 31, 2025. The notice has no immediate effect on trading but requires a compliance plan within 60 days, with potential extension up to October 12, 2026; failure could lead to delisting. Potential delisting risks include reduced liquidity, limited financing access, and impaired employee incentives, with no assurance of regaining compliance.

• ·Nasdaq Listing Rule 5250(c)(1) requires timely filing of periodic reports with SEC
• ·Company has 60 calendar days from April 17, 2026, to submit compliance plan
• ·Nasdaq may grant up to 180 calendar days from 10-K due date (until October 12, 2026) if plan accepted
• ·Appeal opportunity to Nasdaq hearings panel if plan rejected

23-04-2026

Arvana, Inc. entered into a Settlement Agreement on January 13, 2026, with J.P. Carey Enterprises, Inc. to resolve claims totaling $188,379.32 through the issuance of an undetermined number of common stock shares at a 40% discount, plus an additional 250,000 shares for legal fees, approved by court order on April 11, 2026. While this resolves ongoing litigation without cash outlay, it poses significant shareholder dilution risk as the variable share issuance could exceed current outstanding shares and is subject to a 4.99% beneficial ownership limit, requiring multiple tranches.

• ·Settlement Agreement dated January 13, 2026; Court fairness hearing on April 7, 2026; Order entered April 11, 2026.
• ·Litigation: J.P. Carey Enterprises, Inc. v. Arvana, Inc., Case No. CACE-26-000427, Circuit Court of the Seventeenth Judicial Circuit, Broward County, Florida.
• ·Shares issued under Section 3(a)(10) exemption; Company must maintain sufficient authorized shares and avoid impairing stock trading status.

23-04-2026

Immunic, Inc. amended its Certificate of Incorporation to effect a 1-for-10 reverse stock split of its common stock, effective at 12:01 AM Eastern Time on April 27, 2026. Under the amendment, every 10 shares of old common stock are reclassified into 1 share of new common stock, with no fractional shares issued; instead, fractional interests are aggregated, sold on the open market, and proceeds distributed in cash to affected holders. The amendment was duly adopted by the board of directors and stockholders pursuant to Delaware law.

• ·Certificate executed on April 22, 2026
• ·Filing date: April 23, 2026
• ·Common stock par value: $0.0001 per share

23-04-2026

Axos Bank, a subsidiary of Axos Financial, Inc., entered into a Purchase and Assumption Agreement with Capital One, National Association on April 22, 2026, to acquire the IRA custodial business, including traditional and Roth IRA accounts (excluding Closed Accounts and Excluded Accounts), related Acquired Assets, and Assumed Liabilities such as Deposits in CD and Savings Accounts. The transaction includes a Deposit Premium Amount (redacted) based on aggregate Deposit balances as of Closing and requires Regulatory Approvals, including from the OCC under the Bank Merger Act. No specific quantitative portfolio sizes or values were disclosed.

• ·Cut-Off Date: seven (7) days prior to Closing Date
• ·Opt-Out Date: specified in Transfer Communication for account holder objections
• ·Closing effective at 12:01 a.m. Eastern time on Closing Date
• ·Knowledge defined by specific individuals for Seller (Rich Finn, David Roberts) and Purchaser (Greg Garrabrants, Derrick Walsh, Johnny Lai)

23-04-2026

VolitionRx Limited's plan to address NYSE American continued listing standard deficiencies under Sections 1003(a)(i), (ii), and (iii)—requiring minimum stockholders' equity of $2.0M, $4.0M, or $6.0M based on years of reported losses—was accepted on April 22, 2026, granting an extension until August 6, 2027, to regain compliance. The company's common stock (VNRX) will continue trading on NYSE American with no immediate delisting impact or effect on operations. However, failure to meet progress goals could lead to delisting proceedings.

• ·Previous non-compliance notice received February 9, 2026.
• ·Compliance plan submitted by March 8, 2026 deadline.
• ·Subject to periodic review by NYSE American during Plan Period.

23-04-2026

Synera Studio Inc entered into a Software Development Agreement with LUMARK HK LIMITED on April 20, 2026, for the design, development, and delivery of a custom software video editor application for Windows, commencing April 16, 2026, for a 22-week term. The total contract price is $70,380, payable as a $30,000 advance upon execution and $40,380 upon completion and acceptance. The agreement includes provisions for IP transfer post-acceptance, termination for convenience by the Company without further payment obligations, and a liability cap equal to total payments made.

• ·Agreement filed as Exhibit 10.1
• ·Company is an emerging growth company
• ·Principal executive offices: Kamenicka Street 7, Topola, Serbia 34310
• ·Governing law, confidentiality, indemnification, and warranties included
• ·Liability limited to total amount paid by Company

23-04-2026

The 8-K filing discloses the Pooling and Servicing Agreement (PSA) dated and effective as of April 1, 2026, for Commercial Mortgage Pass-Through Certificates, Series 2026-C66, establishing the trust structure for a commercial mortgage-backed securities issuance. Key parties include Wells Fargo Commercial Mortgage Securities, Inc. as Depositor, Trimont LLC as Master Servicer, LNR Partners, LLC as Special Servicer, Computershare Trust Company, National Association as Certificate Administrator, Deutsche Bank National Trust Company as Trustee, and Belloak, LLC as Operating Advisor and Asset Representations Reviewer. No financial performance metrics, period comparisons, or quantitative data are provided in the filing.

• ·Filing Type: 8-K, Items: 1.01, 9.01, dated April 23, 2026
• ·Subcategory: Material Agreement Entry
• ·Includes exhibits such as Mortgage Loan Schedule (Exhibit B), Class A-SB Planned Principal Balance Schedule (Schedule 2), and various certification forms

23-04-2026

Semnur Pharmaceuticals, Inc. terminated two material securities purchase agreements on April 20, 2026, without issuing any shares under either: the deSPAC PIPE SPA with JW Capital Securities Limited for 1,250,000 shares at $16.00 per share (potential $20M proceeds) and the Semnur/Biconomy SPA with Biconomy PTE. Ltd. for 6,250,000 shares at $16.00 per share payable in Bitcoin (potential $100M proceeds). These agreements were entered into in August and September 2025 in connection with the September 22, 2025 Business Combination.

• ·deSPAC PIPE SPA originally dated August 20, 2025; closing extended but never occurred.
• ·Semnur/Biconomy SPA dated September 23, 2025.
• ·Terminations effective April 20, 2026, pursuant to Section 8 of each SPA.
• ·Company headquartered at 960 San Antonio Road, Palo Alto, California, 94303.

23-04-2026

MaxLinear reported Q1 2026 net revenue of $137.2 million, up 1% sequentially from Q4 2025 and 43% YoY from Q1 2025, driven by infrastructure segment growth of 136% YoY from optical data center products. However, GAAP gross margin dipped slightly to 57.5% from 57.6% sequentially, operating expenses rose to $96.1 million (up ~3% seq), resulting in GAAP operating loss of 13% of revenue (worsening from 11% prior quarter) and diluted loss per share of $0.52 (vs $0.17 prior quarter). Non-GAAP operating income remained flat at 16% of revenue with EPS of $0.22 (up from $0.19), and the company amended its credit agreement to extend maturity to March 2028 and increase the facility by $30 million to $130 million available.

• ·Q2 2026 net revenue outlook: $160 million to $170 million
• ·Q2 GAAP gross margin outlook: 56.0% to 59.0%; non-GAAP: 58.0% to 61.0%
• ·Conference call: April 23, 2026 at 1:30 p.m. PT; replay available until May 7, 2026

23-04-2026

Venture Global Calcasieu Pass, LLC (VGCP), a subsidiary of Venture Global, Inc. (NYSE: VG), closed a $750,000,000 offering of 6.000% senior secured notes due 2036. Net proceeds, combined with cash on hand and hedge termination proceeds, were used to fully prepay VGCP's outstanding term loans and cover offering-related fees and expenses. The notes are guaranteed by affiliate TransCameron Pipeline, LLC and secured on a pari passu basis by first-priority interests in assets securing VGCP's existing credit facilities and notes.

• ·Notes mature on May 1, 2036
• ·Notes not registered under the Securities Act of 1933 and may not be offered or sold absent registration or exemption
• ·Venture Global's projects include Calcasieu Pass, Plaquemines LNG, and CP2 LNG in Louisiana
• ·Investor contact: IR@ventureglobalLNG.com; Media contact: press@ventureglobalLNG.com

23-04-2026

U.S. GoldMining Inc. entered into an Amendment Agreement dated April 23, 2026, with Continental Stock Transfer & Trust Company, amending Section 7(a) of the original Warrant Agency Agreement dated March 9, 2023. The key change grants the Company sole discretion to extend the Termination Date of Warrants issued in connection with its IPO of 2,000,000 units, each consisting of one share of Common Stock and one Warrant. The amendment does not adversely affect Warrant holders in a material respect and maintains all other terms of the original agreement.

• ·Original Warrant Agency Agreement dated March 9, 2023.
• ·Effective registration statement on Form S-1 (File No. 333-269693).
• ·Amendment executed under Section 20(a) of the Agency Agreement, without requiring approval of Warrant holders.

23-04-2026

LiveOne, Inc. entered into a Shares Issuance Agreement on April 17, 2026, with Broadcast Music, LLC (BMI) and its subsidiary Slacker, Inc., agreeing to issue 1,000,000 shares of common stock at a deemed price of $7.50 per share as full payment for music royalty obligations through March 31, 2027. The agreement also extends the related License Agreements through December 31, 2027, with automatic yearly renewals thereafter, and BMI agreed to volume restrictions on share sales (max 5% of ADTV, min 3,500 shares per day). No cash proceeds will be received by the Company, representing a non-cash settlement of liabilities.

• ·Shares issued pursuant to effective S-3 Registration Statement (File No. 333-284916), prospectus supplement filed April 23, 2026.
• ·License Agreements originally dated November 20, 2024, amended April 17, 2026.
• ·Settlement of share issuance expected on or about April 24, 2026.
• ·Post-April 1, 2027 obligations payable in cash.

23-04-2026

Digital Turbine, Inc. amended its Financing Agreement on April 20, 2026, reducing the liquidity covenant requirement to $15,000,000 for the period from April 1, 2026, to December 31, 2026. The company also amended certain outstanding warrants to suspend registration rights for the resale of underlying common stock shares until October 1, 2026. These actions are detailed in Exhibits 10.2 and 4.2 of the filing.

• ·Financing Agreement originally dated August 29, 2025 (Exhibit 10.1)
• ·Warrants form incorporated from September 2, 2025 8-K (Exhibit 4.1)

23-04-2026

Datavault AI Inc. entered into a Subscription Agreement dated April 16, 2026, to acquire 8,163,265 shares of Vivasor, Inc.'s Series A Common Stock at $6.125 per share for an aggregate purchase price of $50 million, to be paid entirely in non-cash consideration via the issuance of 75,942,666 shares of the Company's common stock. On April 23, 2026, the Company filed a prospectus supplement to its effective shelf registration statement (File No. 333-294502) to register the Datavault shares issued in the transaction. No financial performance metrics or comparisons are provided in the filing.

• ·Subscription Agreement filed as Exhibit 10.1
• ·Opinion of counsel by Paul Hastings LLP filed as Exhibit 5.1
• ·Prospectus supplement filed April 23, 2026, to shelf registration originally filed March 20, 2026, and effective March 25, 2026 (File No. 333-294502)

23-04-2026

FS CREIT Finance BB-1 LLC entered into the Tenth Amendment to its Master Repurchase Agreement with Barclays Bank PLC on April 21, 2026, extending the Availability Period to February 21, 2029. The Seller represents and warrants no Material Adverse Effect, Margin Deficit, Default, or Event of Default is occurring, and all prior representations remain true. A Funding Fee is due on February 21, 2028, along with Purchaser's expenses.

• ·Amendment filed as 8-K on April 23, 2026 under Items 1.01, 2.03, 9.01
• ·Original Master Repurchase Agreement dated February 22, 2021, with multiple prior amendments up to Ninth on April 1, 2025
• ·Governed by New York law

23-04-2026

Catheter Precision, Inc., a Delaware corporation, adopted a Certificate of Designation via board resolutions for up to 3,470 shares of Series C-2 Convertible Preferred Stock out of 10,000,000 authorized preferred shares ($0.0001 par value), with 15,190 shares currently issued and outstanding. The terms include conversion rights, beneficial ownership limitations, and protective covenants restricting new indebtedness, liens, dividends, affiliate transactions, asset dispositions, acquisitions exceeding 10% of assets, mergers, and changes of control, applicable while 33.33% of the series remains outstanding. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Covenants prohibit acquisitions or joint ventures for aggregate consideration exceeding 10% of consolidated assets as of most recent quarter-end.
• ·Acquisition limit based on consolidated balance sheet prepared in accordance with GAAP.

23-04-2026

Boxlight Corporation received a Nasdaq notice on April 20, 2026, stating that its stockholders’ equity of $1,255,000 as of December 31, 2025, falls short of the $2,500,000 minimum required under Nasdaq Listing Rule 5550(b)(1) for continued listing on the Nasdaq Capital Market. While there is no immediate impact on trading and the company has until June 4, 2026, to submit a compliance plan (potentially granting 180 days), failure to regain compliance risks delisting. The company is evaluating options and expresses confidence in compliance but provides no assurances.

• ·Compliance plan, if accepted, grants up to 180 calendar days from April 20, 2026, to evidence compliance.
• ·Company does not currently meet alternative Nasdaq continued listing standards.
• ·Nasdaq rules permit appeal of delisting determination to a Nasdaq Hearings Panel.

23-04-2026

Borealis Foods Inc. received a Nasdaq notice on April 17, 2026, stating non-compliance with Listing Rule 5250(c)(1) due to the delayed filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The notice has no immediate effect on the listing or trading of its common shares (BRLS) or warrants (BRLSW) on the Nasdaq Capital Market, but the company must submit a compliance plan by June 16, 2026, with potential extension to October 12, 2026. The company intends to file the 10-K no later than May 2026 to regain compliance.

• ·Nasdaq Commission File Number: 001-40778
• ·I.R.S. Employer Identification Number: 98-1638988
• ·Fiscal year end: December 31

23-04-2026

Paycom Software, Inc. (Holdings) and Paycom Payroll, LLC (Borrower) entered into an Amended and Restated Credit Agreement dated April 23, 2026, amending and restating the prior Credit Agreement from July 29, 2022. The agreement increases the aggregate Revolving Commitment to $2,125,000,000 and extends the Maturity Date for the Revolving Commitment. JPMorgan Chase Bank, N.A. acts as Administrative Agent, with various banks serving as Co-Documentation Agents and Joint Bookrunners.

• ·Amends and restates Existing Credit Agreement dated July 29, 2022
• ·Re-evidences Obligations from the Existing Credit Agreement
• ·Includes provisions for Term Loans, Swingline Loans, and Letters of Credit

23-04-2026

Green Plains Inc. and subsidiaries entered into a Second Amendment to their Loan and Security Agreement effective April 17, 2026, reducing the Aggregate Revolving Loan Commitment from $350 million to $300 million. However, the Scheduled Termination Date was extended six months from March 25, 2027, to September 25, 2027. Minor updates were made to definitions, sanctions clauses, and lender commitments schedule.

• ·Amendment ratified all existing liens and security interests.
• ·No Default or Event of Default existing post-amendment.
• ·Schedule 1.1 (Revolving Loan Commitments) omitted as confidential.

23-04-2026

Lucid Diagnostics Inc. announced the pricing of an underwritten registered direct offering of 18,000,000 common shares at $1.00 per share, anchored by a $15 million investment from a fundamental institutional investor with support from a large existing shareholder. Gross proceeds are expected to be approximately $18 million before deducting underwriting discounts and other expenses, to be used for working capital and general corporate purposes. The offering is expected to close on or about April 24, 2026, subject to customary closing conditions.

• ·Offering pursuant to shelf registration statement on Form S-3 (File No. 333-291981) effective March 26, 2026.
• ·Joint bookrunners: Canaccord Genuity LLC and BTIG, LLC.

23-04-2026

Mawson Infrastructure Group Inc. filed an 8-K on April 23, 2026, including Item 3.01 (Notice of Delisting or Failure to Satisfy a Listing Rule) and Item 5.03 (amendment to Certificate of Incorporation). The amendment changes the company's name to Big Digital Energy, Inc., filed with Delaware Secretary of State on April 20, 2026, at 4:03 PM, and effective April 24, 2026. The amendment was signed by CEO Phil Stanley.

• ·File Number: 5081043
• ·Delaware Division of Corporations SR#: 20261912116

23-04-2026

Triller Group Inc. received a delisting determination letter from Nasdaq on April 17, 2026, for failing to comply with the Minimum Bid Price Requirement (Nasdaq Rule 5550(a)(2)), as its common stock closing bid price was below $1 per share as of December 29, 2025, after a 180-day cure period from June 30, 2025. Trading had been suspended from December 30, 2025, to April 15, 2026, due to prior non-compliance with periodic filing rules but resumed after filing the 10-K for year-ended December 31, 2025. The Listing Council remanded the bid price matter to the Hearings Panel on April 21, 2026, with potential review and stay of delisting if no further compliance period is granted, though no assurance of regaining compliance exists.

• ·Deficiency Notice received June 30, 2025, providing 180 calendar days to regain compliance until December 29, 2025.
• ·Nasdaq Hearings Panel decision to delist issued December 26, 2025, modified by Listing Council on March 24, 2026.
• ·Company submitted response to Hearings Panel on April 23, 2026, requesting new exception period under Rule 5815(c)(1)(A).

23-04-2026

Jefferson Capital Systems, LLC (JCap) and affiliates (CL Holdings, LLC, JC International Acquisition, LLC, and CFG Canada Funding, LLC) entered into Amendment No. 8 to their Credit Agreement, increasing the maximum Aggregate Commitment to $1,425,000,000 and establishing a $150,000,000 Incremental Commitment from new Incremental Lenders. Citizens Bank, N.A. serves as Administrative Agent, with Bank of Montreal and Deutsche Bank Securities Inc. as joint lead arrangers. The amendment updates sanctions-related definitions and compliance representations, effective upon satisfaction of specified conditions including no Default.

• ·Original Credit Agreement dated May 21, 2021, with prior amendments on December 28, 2021; February 28, 2022; April 26, 2023; September 29, 2023; June 3, 2024; November 13, 2024; and October 27, 2025.
• ·Amendment effective upon receipt of executed counterparts, secretary's certificates, good standing certificates, KYC documentation, solvency certificate, fees, and confirmation of no Default.
• ·Updated definitions for 'Sanctioned Country', 'Sanctioned Person', and 'Sanctions' to include additional jurisdictions like EEA Member Countries and Government of Canada.

23-04-2026

On April 17, 2026, Viking Ozone Technology, LLC, a majority-owned subsidiary of Viking Energy Group, Inc. (wholly-owned by Camber Energy, Inc.), issued a $500,000 promissory note to an accredited investor at 10% fixed interest, maturing on the earlier of April 15, 2027 or proceeds from the sale of its VKIN-300 waste treatment unit. The note is secured by a priority interest in net sale proceeds from the unit and may be part of a series totaling up to $750,000. Camber Energy is not a party to the note, which includes no conversion rights or warrants.

• ·Note includes customary events of default, such as failure to pay or bankruptcy events, triggering immediate due and payable status and 10% per annum default interest.
• ·Security is a priority interest (pari passu with other noteholders in the series) solely over net sale proceeds from the VKIN-300 unit sale.

23-04-2026

Anteris Technologies Global Corp., through its wholly owned subsidiary Anteris Technologies Corporation, entered into a lease agreement with Northcross West Industrial Owner, LLC for approximately 181,436 square feet of office and warehouse space in Brooklyn Park, Minnesota. The lease has an initial term from September 1, 2026, to August 31, 2037, with two optional 84-month extensions at market rent. Monthly minimum rent starts at $152,708.63, subject to full abatement for the first three months, partial abatement for the next nine months, annual escalations, real estate taxes, operating expenses, and other charges.

• ·Full text of the lease to be filed as an exhibit to the Form 10-Q for the three months ended March 31, 2026.
• ·Rent abatements apply only if the Company is not in default.

23-04-2026

NextNRG, Inc. entered into a Securities Purchase Agreement dated April 15, 2026, with AGILE HUDSON PARTNERS LLC for the sale of a Note, Commitment Shares, and potential Conversion Shares, relying on Section 4(a)(2) and Rule 506(b) exemptions. The agreement mandates shareholder approval within 180 days for issuances exceeding the 10,000,000 share Exchange Cap, purchase of D&O insurance within 60 days with 18-month coverage and 2-year tail, and imposes $3,000 per day liquidated damages for failure to disclose material non-public information via Form 8-K. No operational or financial performance metrics are disclosed.

• ·Agreement governed by Delaware law with binding arbitration provisions in Delaware.
• ·Company must issue irrevocable transfer agent instructions and reserve shares per Note terms.
• ·Buyer not to be asserted as a broker-dealer absent court adjudication.
• ·Breaches of covenants trigger Event of Default under the Note.

23-04-2026

On April 17, 2026, Sports Entertainment Gaming Global Corporation (SEGG) received a Nasdaq notice of non-compliance with Listing Rule 5250(c)(1) due to failure to timely file its Form 10-K for the fiscal year ended December 31, 2025. The notice has no immediate effect on the listing of its common stock (SEGG) or warrants (LTRYW) on Nasdaq, but the company must submit a compliance plan within 60 calendar days, with potential extension up to 180 days if accepted. The company intends to file the 10-K as soon as practicable.

• ·Compliance plan due within 60 calendar days from April 17, 2026
• ·Potential extension of up to 180 calendar days from original 10-K due date if plan accepted
• ·Registrant address: 5049 Edwards Ranch Rd., 4th Floor, Fort Worth, Texas 76109
• ·Emerging growth company status confirmed

23-04-2026

zSpace, Inc. disclosed receipt of a notification from Nasdaq in accordance with Listing Rule 5810(b), signaling failure to satisfy a listing requirement, likely bid price deficiency, which could lead to delisting. The company plans to appeal the determination to a hearings panel. No compliance assurances were provided, highlighting ongoing risks to Nasdaq listing status.

• ·Notification dated 2026-04-21
• ·References Annual Report on Form 10-K for year ended December 31, 2025

23-04-2026

On April 21, 2026, SmartKem, Inc. received notification from the Nasdaq Hearings Panel that it has regained compliance with the stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(2) and all other applicable criteria for continued listing on The Nasdaq Capital Market. However, the company remains subject to a grace period until September 1, 2026, to meet the bid price requirement under Rule 5550(a)(2), and is under a one-year Discretionary Panel Monitor per Rule 5815(d)(4)(A), with no further grace periods if it fails during this time. This partial compliance regain avoids immediate delisting but highlights ongoing listing risks.

• ·Common Stock, par value $0.0001 per share, trading symbol SMTK.
• ·Emerging growth company status confirmed.

23-04-2026

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced an agreement to sell its branded U.S. pharmaceuticals business to an Apotex affiliate for $100 million in cash, subject to shareholder approval, unlocking value and allowing focus on its orphan drug pipeline. The retained pipeline includes ifetroban in Phase II for cardiomyopathy associated with Duchenne muscular dystrophy (DMD, with breakthrough results, Orphan Drug, Rare Pediatric Disease, and Fast Track designations), Systemic Sclerosis (SSc, enrollment completed), and Idiopathic Pulmonary Fibrosis (IPF, enrollment underway). No financial declines or flat metrics reported.

• ·Transaction requires Cumberland shareholder authorization and approval.
• ·Cumberland retains majority ownership in Cumberland Emerging Technologies Inc.
• ·DMD program interactions with FDA underway regarding Phase II results and approval requirements.
• ·SSc study enrollment completed; top-line results pending.
• ·IPF Phase II study enrollment well underway; interim safety and efficacy results pending.

23-04-2026

Inventurus Knowledge Solutions, Inc. (IKS Health) announced a definitive agreement to acquire TruBridge, Inc. (NASDAQ: TBRG) for $26.25 in cash per share, with the transaction approved by both boards and supported by shareholders controlling approximately 27% of TruBridge's outstanding shares. The acquisition aims to combine IKS Health's AI-driven care enablement with TruBridge's revenue cycle management and EHR solutions to serve over 2,000 healthcare organizations and 150,000 clinicians, particularly in rural areas, and is expected to close in the third calendar quarter of 2026 subject to shareholder approvals, HSR clearance, and other customary conditions. The deal will be financed primarily through new indebtedness, including a term loan from Citibank, JPMorgan Chase, and Deutsche Bank.

• ·Acquisition financed primarily through new indebtedness, including a term loan underwritten by Citibank, JPMorgan Chase, and Deutsche Bank, subject to IKS Health shareholder approval.
• ·Advisors: Solomon Partners Securities, LLC (exclusive financial advisor to TruBridge); J.P. Morgan Securities LLC and Citigroup Global Markets India Private Limited (financial advisors to IKS Health).

23-04-2026

CarMax Auto Owner Trust 2026-2 entered into a Sale and Servicing Agreement dated April 1, 2026, with CarMax Auto Funding LLC as Depositor and CarMax Business Services, LLC as Servicer. The Depositor irrevocably sells, transfers, and conveys a pool of motor vehicle retail installment sale contracts (Receivables), related security interests in Financed Vehicles, and other Trust Property to the Trust in exchange for Notes and Certificates. The Servicer will administer and service the Receivables, with provisions for collections, distributions, reserve accounts, and repurchase remedies upon breaches of representations and warranties.

• ·Agreement filed as Exhibit 99.1 in 8-K on April 23, 2026 (Items 1.01, 8.01, 9.01).
• ·Transfer intended as a true sale; if recharacterized, constitutes a first priority security interest.
• ·Rights under Receivables Purchase Agreement conveyed, including Seller repurchase obligations.